Serina Therapeutics Inc - Company & Market Research Reports

Serina Therapeutics is a private pharmaceutical company founded in 2006 at the Hudson Alpha Institute of Biotechnology in Huntsville, Alabama. They have developed and patented much of the polymer technology known as PEG, or PEGylation. Peg is accepted widely as the polymer standard and many drugs are developed with this formula. It develops drugs to treat neurological diseases, cancer, pain and refractory epilepsy as well as movement disorders such as Parkinson's disease. The design of this drug is to optimize therapeutic outcomes, safety and quality of life for the patients.


Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 - Product Thumbnail Image

Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021

  • Report
  • 382 Pages
From
Sleep Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Sleep Disorders Drug Development Pipeline Review, 2017

  • Report
  • 76 Pages
From
Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & Biosuperiors - Product Thumbnail Image

Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & Biosuperiors

  • Report
  • 1342 Pages
From
Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins) - Product Thumbnail Image

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

  • Report
  • 301 Pages
From
Post-Operative Pain - Pipeline Review, H1 2018 - Product Thumbnail Image

Post-Operative Pain - Pipeline Review, H1 2018

  • Report
  • 218 Pages
From
Post-Operative Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Post-Operative Pain - Pipeline Review, H2 2017

  • Report
  • 191 Pages
From
Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026 - Product Thumbnail Image

Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026

  • Report
  • 183 Pages
From
Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017

  • Report
  • 139 Pages
From
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2018 - Product Thumbnail Image

Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2018

  • Report
  • 85 Pages
From
Emesis (Vomiting) - Pipeline Insight, 2018 - Product Thumbnail Image

Emesis (Vomiting) - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2018 - Product Thumbnail Image

Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2018

  • Drug Pipelines
  • 147 Pages
From
Epilepsy - Pipeline Review, H1 2018 - Product Thumbnail Image

Epilepsy - Pipeline Review, H1 2018

  • Report
  • 418 Pages
From
Parkinson's Disease - Pipeline Review, H2 2017 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H2 2017

  • Report
  • 831 Pages
From
Restless Legs Syndrome - Pipeline Review, H1 2018 - Product Thumbnail Image

Restless Legs Syndrome - Pipeline Review, H1 2018

  • Report
  • 47 Pages
From
Restless Legs Syndrome - Pipeline Review, H2 2017 - Product Thumbnail Image

Restless Legs Syndrome - Pipeline Review, H2 2017

  • Report
  • 44 Pages
From
Parkinson's Disease - Pipeline Review, H1 2017 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H1 2017

  • Report
  • 803 Pages
From
Restless Legs Syndrome - Pipeline Insight, 2018 - Product Thumbnail Image

Restless Legs Syndrome - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Antibody Drug Conjugates Market (4th Edition) 2017-2030 - Product Thumbnail Image

Antibody Drug Conjugates Market (4th Edition) 2017-2030

  • Report
  • 556 Pages
From
HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026 - Product Thumbnail Image

HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026

  • Report
  • 345 Pages
From
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis - Product Thumbnail Image

Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis

  • Report
  • 470 Pages
From
Loading Indicator
adroll